(7) found that in 219 SGC patients, the 5-year DFS rates of patients showing tumor cell PD-L1 positivity and PD-L1 negativity were 20.2% and 54.6%, respectively, and the difference was significant. The gene discussed is CD274; the disease is neoplasm.